Florida/Georgia Personal Injury & Workers Compensation

You're probably overthinking it. Call a lawyer.

Call Now: 904-383-7448
Florida Statute 409.91195 - Full Text and Legal Analysis
Florida Statute 409.91195 | Lawyer Caselaw & Research
Link to State of Florida Official Statute
F.S. 409.91195 Case Law from Google Scholar Google Search for Amendments to 409.91195

The 2025 Florida Statutes

Title XXX
SOCIAL WELFARE
Chapter 409
SOCIAL AND ECONOMIC ASSISTANCE
View Entire Chapter
409.91195 Medicaid Pharmaceutical and Therapeutics Committee.There is created a Medicaid Pharmaceutical and Therapeutics Committee within the agency for the purpose of developing a Medicaid preferred drug list.
(1) The committee shall be composed of 11 members appointed by the Governor. Four members shall be physicians, licensed under chapter 458; one member licensed under chapter 459; five members shall be pharmacists licensed under chapter 465; and one member shall be a consumer representative. The members shall be appointed to serve for terms of 2 years from the date of their appointment. Members may be appointed to more than one term. The agency shall serve as staff for the committee and assist them with all ministerial duties. The Governor shall ensure that at least some of the members of the committee represent Medicaid participating physicians and pharmacies serving all segments and diversity of the Medicaid population, and have experience in either developing or practicing under a preferred drug list. At least one of the members shall represent the interests of pharmaceutical manufacturers.
(2) Committee members shall select a chairperson and a vice chairperson each year from the committee membership.
(3) The committee shall meet at least quarterly and may meet at other times at the discretion of the chairperson and members. The committee shall comply with rules adopted by the agency, including notice of any meeting of the committee pursuant to the requirements of the Administrative Procedure Act.
(4) Upon recommendation of the committee, the agency shall adopt a preferred drug list as described in s. 409.912(5). To the extent feasible, the committee shall review all drug classes included on the preferred drug list every 12 months, and may recommend additions to and deletions from the preferred drug list, such that the preferred drug list provides for medically appropriate drug therapies for Medicaid patients which achieve cost savings contained in the General Appropriations Act.
(5) Except for antiretroviral drugs, reimbursement of drugs not included on the preferred drug list is subject to prior authorization.
(6) The agency shall publish and disseminate the preferred drug list to all Medicaid providers in the state by Internet posting on the agency’s website or in other media.
(7) The committee shall ensure that interested parties, including pharmaceutical manufacturers agreeing to provide a supplemental rebate as outlined in this chapter, have an opportunity to present public testimony to the committee with information or evidence supporting inclusion of a product on the preferred drug list. Such public testimony shall occur prior to any recommendations made by the committee for inclusion or exclusion from the preferred drug list. Upon timely notice, the agency shall ensure that any drug that has been approved or had any of its particular uses approved by the United States Food and Drug Administration under a priority review classification will be reviewed by the committee at the next regularly scheduled meeting following 3 months of distribution of the drug to the general public.
(8) The committee shall develop its preferred drug list recommendations by considering the clinical efficacy, safety, and cost-effectiveness of a product.
(9) The Medicaid Pharmaceutical and Therapeutics Committee may also make recommendations to the agency regarding the prior authorization of any prescribed drug covered by Medicaid.
(10) Medicaid recipients may appeal agency preferred drug formulary decisions using the Medicaid fair hearing process administered by the Agency for Health Care Administration.
History.s. 72, ch. 2000-367; s. 8, ch. 2001-104; s. 25, ch. 2002-400; s. 15, ch. 2005-60; s. 15, ch. 2011-135; s. 207, ch. 2014-19; s. 26, ch. 2015-3; s. 15, ch. 2017-4; s. 3, ch. 2021-151.

F.S. 409.91195 on Google Scholar

F.S. 409.91195 on CourtListener

Amendments to 409.91195


Annotations, Discussions, Cases:

Cases Citing Statute 409.91195

Total Results: 3  |  Sort by: Relevance  |  Newest First

Copy

Pharm. Rsch. & Mfrs. of Am. v. Meadows, 304 F.3d 1197 (11th Cir. 2002).

Cited 22 times | Published | Court of Appeals for the Eleventh Circuit | 2002 U.S. App. LEXIS 18487, 2002 WL 31000006

...The central issue is whether there is a conflict between the recently enacted Florida law and the governing federal Medicaid statute, 42 U.S.C. § 1396r-8. The state of Florida argues that the new Florida law, ch. 2001-104, codified at Fla. Stat. § 409.91195, 409.912, provides for a “prior authorization program” within the meaning of 42 U.S.C....
...See § 1396r-8(d)(4)(C). B. In the spring of 2001, the Florida legislature passed the law that forms the basis of the present controversy. See Laws of Florida, ch. 2001-104 (“the 2001 amendments”), amending Fla. Stat. §§ 409.91195, 409.912.1 After Governor Bush signed the bill, the Florida law went into effect on July 1, 2001....
...ces under which a state Medicaid plan can restrict coverage of Medicaid-eligible outpatient drugs. Unfortunately, the terminology adopted by the Florida law has at least two ambiguities that have produced the current controversy. First, section 409.91195 mandates the creation of a “preferred drug formulary,” which seems to be an imprecise parallel to a “formulary” within the meaning of § 1396r-8(d)(1)(B)(iv), (d)(4). Second, the term “preferred drug formulary” is used interchangeably 1 The text of §§ 409.91195, 409.912(37) are reproduced in an appendix to this opinion. 10 throughout section 409.91195 with the term “preferred drug list.”2 The reference to a “preferred” drug list or “preferred” drug formulary appears to be unique to the Florida statute, since the term “formulary” in § 1396r-8 is not modified by...
...usly represents an attempt by the Florida legislature to conform a “preferred drug formulary” to at least some of the requirements of a “formulary” as defined by the federal Medicaid statutes. For example, the first sentence of Fla. Stat. § 409.91195 reads as follows: “There is created a Medicaid Pharmaceutical and Therapeutics Committee within the Agency for Health Care Administration for the purpose of developing a preferred drug 2 The Report and Recommendation of the federal...
...e judge, which was subsequently adopted by the district court, makes the following rather succinct observation: The Florida statutes use the phases “preferred drug formulary” and “preferred drug list” interchangably. E.g., Fla. Stat. § 409.91195(1), (4), (6), (7), (8), (9), (11)....
...develop a formulary within the meaning of § 1396r-8(d)(4). Compare § 1396r- 8(d)(4)(A) (“The formulary is developed by a committee consisting of physicians, pharmacists, and other appropriate individuals appointed by the Governor of the State ... .”), with Fla. Stat. § 409.91195(1) (“The Medicaid Pharmaceutical and Therapeutics Committee [charged with the development of a preferred drug formulary] shall be comprised as specified in 42 U.S.C....
...terms of safety, effectiveness, or clinical outcome of such treatment for such population over other drugs included in the formulary and there is a written explanation (available to the public) of the basis for the exclusion.”), with Fla. Stat. § 409.91195(9) (“The Medicaid Pharmaceutical and Therapeutics Committee shall develop its preferred drug list recommendations by considering the clinical efficacy, safety, and cost- effectiveness of a product.” (emphasis added)), and Fla. Stat. § 409.91195(4) (“To the extent feasible, the committee shall review all drug classes included in the formulary at least every 12 months, and may recommend additions to and deletions from the formulary, such that the formulary provides for medic...
...e submitted to the CMS proposed revisions to the State’s Medicaid Plan, including deletion of the phrase “preferred drug formulary,” replacing it with “preferred drug list.”5 The new sentence reads, “In accordance with Florida Statute 409.91195 and pursuant to 42 U.S.C....
...If the Florida law created a Medicaid 20 “formulary,” we would agree with the PhRMA that Florida officials developing the preferred drug list could not consider a drug’s “cost-effectiveness,” as required under Fla. Stat. § 409.91195(9), when the governing federal statute clearly limits such decisions to clinical issues of safety and drug effectiveness....
...ith comparable therapeutic properties that are also more cost-effective for the state. Presumably, some doctors will learn to avoid the prior authorization program by routinely looking for a suitable drug on the “preferred drug list,” Fla. Stat. § 409.91195(4); hence, the shifts in market share following the enactment of the Florida law....
...By stretching its Medicaid dollars, the Florida law has the potential for providing more and better medical services to the target population. Finally, because Florida’s preferred drug list is based on both clinical and cost-related factors, see Fla. Stat. § 409.91195(9) (requiring that preferred drug list recommendations be based on “clinical efficacy, safety, and cost-effectiveness of a product”), the Florida law leaves open the possibility that a medically superior drug will be included on t...
...Instead, the Florida law merely conditions coverage for non-preferred drugs on whether the prescribing physician has followed the prior authorization procedure. If this case presents us with difficult issues of statutory interpretation, this difficulty arises from the confusing phraseology of the Florida law. Section 409.91195 begins with the sentence, “There is created a Medicaid Pharmaceutical and Therapeutics Committee within the Agency for Health Care Administration [AHCA] for the purpose of developing a preferred drug formulary pursuant to 42 U.S.C....
...However, the term “preferred drug formulary” does not appear in the governing Medicaid statute, and the reference to § 1396r-8 resolves nothing; a prior authorization program is defined in subsections (d)(1)(A) and (d)(5), while a “formulary” is defined in subsections (d)(1)(B) and (d)(4). Further, section 409.91195 of the Florida law uses the term “preferred drug 30 formulary” interchangeably with “preferred drug list”: subsections (1) and (6) refer to “preferred drug formulary”; subse...
...ulary, as required by § 1396r- 8(d)(4)(C). The AHCA insists that the Florida law permits the state to implement a conforming Medicaid formulary at a later date, and that the Medicaid Pharmaceutical and Therapeutics Committee, created pursuant to section 409.91195, would already be in place to assume this additional duty....
...The AHCA has adopted a reasonable construction of the Florida law that comports with the requirements of the governing federal Medicaid statute. The judgment of the district court is therefore AFFIRMED. 32 33 Appendix The following is the text of Fla. Stat. § 409.91195: There is created a Medicaid Pharmaceutical and Therapeutics Committee within the Agency for Health Care Administration for the purpose of developing a preferred drug formulary pursuant to 42 U.S.C....
Copy

Edmonds v. Levine, 417 F. Supp. 2d 1323 (S.D. Fla. 2006).

Cited 9 times | Published | District Court, S.D. Florida | 2006 U.S. Dist. LEXIS 9591, 2006 WL 454343

...30 with comparable therapeutic properties that are also more cost-effective for the state. Presumably, some doctors will learn to avoid the prior authorization program by routinely looking for a suitable drug on the "preferred drug list," Fla. Stat. § 409.91195(4); hence, the shifts in market share following the enactment of the Florida law....
Copy

Pharm. Rsch. & Mfrs. of Am. v. Medows, 184 F. Supp. 2d 1186 (N.D. Fla. 2001).

Cited 1 times | Published | District Court, N.D. Florida | 2001 U.S. Dist. LEXIS 22606, 2001 WL 1694101

...Again for the reasons stated by the magistrate judge, this court concludes that the plaintiff's motion for summary judgment and permanent injunctive relief must be denied. The plaintiff asks this court to enjoin enforcement of two recently amended Florida laws: sections 409.91195 and 409.912(37) of the Florida Statutes....
...According to the plaintiff, these laws authorize the creation of a state Medicaid formulary in violation of subsection (d)(4) of section 1927 of the Social Security Act (the "federal Medicaid law"). The magistrate judge determined — and this court agrees — that sections 409.91195 and 409.912(a)(37), as amended in 2001, do not authorize the creation of a "formulary" as that term is used in the federal Medicaid law but, instead, allow the establishment of a "preferred drug list" and a "prior authorization program" expressly permitted by the federal Medicaid law....
...he dispensing of at least 72-hour supply of a covered outpatient prescription drug in any emergency situation (as defined by the Secretary). 42 U.S.C. § 1396r-8(d)(5)(A) and (B). The Florida law which is challenged in this suit consists of sections 409.91195 and 409.912, Florida Statutes, as amended by Chapter 2001-104, Laws of Florida. The new law took effect on July 1, 2001. A copy of the enactment is attachment A to doc. 8. Section 409.91195 has been amended to create a Medicaid Pharmaceutical and Therapeutics Committee within the Agency for Health Care Administration "for the purpose of developing a preferred drug formulary pursuant to 42 U.S.C. § 1396r-8." Id., § 8, amending FLA. STAT. § 409.91195. Upon recommendation of the Committee, the Agency is to "adopt a preferred drug list." Id., amending FLA. STAT. § 409.91195(4)....
...The approval was retroactively effective nunc pro tunc July 1, 2001. Id., ex. F, p. 5. Except for mental health drugs, antiretroviral drugs, and drugs for institutional residents, "reimbursement for drugs not included in the formulary is subject to prior authorization." Id., amending FLA. STAT. § 409.91195(5)....
...The temporary list was adopted in June, 2001, by the existing Medicaid Pharmaceutical and Therapeutics Committee, which had appointees by not only the Governor, but by the presiding officers of the Florida House of Representatives and the Senate. FLA. STAT. § 409.91195(1) (2000) (prior to amendment)....
...Plaintiff argues that the Florida Statutes reflect an intent to create a drug formulary as intended by § 1396r-8(d)(4) because the amended statutes use the word "formulary." The Florida statutes use the phrases "preferred drug formulary" and "preferred drug list" interchangeably. [4] E.g., FLA. STAT. § 409.91195(1), (4), (5), (6), (7), (8), (9), (11)....
...to provide drugs to Medicaid beneficiaries at the lowest cost possible. [5] Plaintiff had argued that the Florida law establishes a Medicaid Pharmaceutical and Therapeutics Committee to be "comprised as specified in 42 U.S.C. § 1396r-8." FLA. STAT. § 409.91195(1)....
...ject. Id. (citation omitted). Dietrich v. Key Bank, N.A., 72 F.3d at 1514. [4] The title to Committee Substitute for Committee Substitute for Senate Bill 792, which became Chapter 2001-104, Laws of Florida, announces that the amendment to FLA. STAT. § 409.91195 will require the establishment of a "preferred drug formulary." Doc....